Nonsteroidal anti-inflammatory drugs and ectodomain shedding of the amyloid precursor protein
Neurodegener Dis. 2009;6(1-2):1-8. Epub 2008 Mar 18.
Authors/Editors: |
Leuchtenberger S Maler J Czirr E Ness J Esselmann H Pietrzik CU Wiltfang J Weggen S |
---|---|
Publication Date: | 2009 |
Type of Publication: | Journal Article |
OBJECTIVE: To clarify whether NSAIDs consistently stimulate sAPP secretion.
METHODS: 293-EBNA cells with stable overexpression of an APP-alkaline phosphatase fusion protein (APP-AP), SH-SY5Y and PC12 cells or primary telencephalic chicken neurons were treated with ibuprofen or indomethacin. APP shedding was then determined by measuring AP activity in conditioned media, Western blot analysis with antibodies against total sAPP or specific for sAPP-alpha, or in a pulse-chase paradigm.
RESULTS: AP activity in conditioned media was not increased after NSAID treatment of 293-EBNA cells whereas it was elevated by phorbol ester. Surprisingly, ibuprofen or indomethacin treatment of SH-SY5Y and PC12 cells expressing endogenous APP did not cause changes in sAPP or sAPP-alpha secretion or downregulation of cellular APP. These findings were further corroborated in primary chicken neuronal cultures.
CONCLUSIONS: Using various experimental settings, we were unable to confirm sAPP or sAPP-alpha stimulation with the NSAIDs ibuprofen and indomethacin in transfected and nontransfected cells of neuronal and nonneuronal origin. Importantly, these findings seem to rule out chronic sAPP stimulation as an alternative mechanism of NSAID action in AD.